Scott D. Grimes - 07 May 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
07 May 2021
Net transactions value
-$540,971
Form type
4
Filing time
11 May 2021, 16:15:42 UTC
Next filing
18 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $80,465 -802 -0.32% $100.33* 249,025 07 May 2021 Direct F1, F2
transaction CDLX Common Stock Sale $131,430 -1,300 -0.52% $101.10* 247,725 07 May 2021 Direct F1, F3
transaction CDLX Common Stock Sale $184,230 -1,800 -0.73% $102.35* 245,925 07 May 2021 Direct F1, F4
transaction CDLX Common Stock Sale $128,874 -1,243 -0.51% $103.68* 244,682 07 May 2021 Direct F1, F5
transaction CDLX Common Stock Sale $15,972 -152 -0.06% $105.08* 244,530 07 May 2021 Direct F1, F6
holding CDLX Common Stock 83,112 07 May 2021 See Footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.81 to $100.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.82 to $101.63, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.90 to $102.83, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $103.185 to $104.14, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.94 to $105.22, inclusive.
F7 The reportable securities are held by the 2013 Scott Grimes GRAT UAD (the "GRAT").